Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 9 studies | 28% ± 11% | |
| lung | 8 studies | 31% ± 11% | |
| brain | 6 studies | 30% ± 7% | |
| kidney | 5 studies | 20% ± 3% | |
| peripheral blood | 4 studies | 23% ± 7% | |
| liver | 4 studies | 28% ± 11% | |
| pancreas | 3 studies | 42% ± 10% | |
| uterus | 3 studies | 31% ± 19% | |
| breast | 3 studies | 20% ± 3% | |
| bone marrow | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 100% | 10973.64 | 966 / 966 | 100% | 243.26 | 527 / 527 |
| prostate | 100% | 10799.43 | 245 / 245 | 100% | 197.75 | 502 / 502 |
| stomach | 100% | 7867.75 | 359 / 359 | 100% | 199.85 | 286 / 286 |
| breast | 100% | 7046.62 | 459 / 459 | 100% | 136.75 | 1117 / 1118 |
| kidney | 100% | 9462.73 | 89 / 89 | 100% | 193.06 | 899 / 901 |
| thymus | 100% | 14319.61 | 653 / 653 | 100% | 130.81 | 602 / 605 |
| esophagus | 100% | 5147.16 | 1443 / 1445 | 99% | 123.50 | 182 / 183 |
| pancreas | 100% | 9230.05 | 328 / 328 | 99% | 86.05 | 176 / 178 |
| skin | 99% | 6839.75 | 1791 / 1809 | 100% | 175.16 | 471 / 472 |
| liver | 100% | 11532.70 | 226 / 226 | 99% | 94.52 | 401 / 406 |
| adrenal gland | 100% | 24560.84 | 258 / 258 | 99% | 131.01 | 227 / 230 |
| brain | 99% | 5108.73 | 2622 / 2642 | 99% | 95.36 | 701 / 705 |
| lung | 99% | 6086.77 | 573 / 578 | 99% | 110.05 | 1149 / 1155 |
| bladder | 100% | 7046.48 | 21 / 21 | 99% | 123.67 | 497 / 504 |
| ovary | 100% | 8033.73 | 180 / 180 | 99% | 94.43 | 424 / 430 |
| uterus | 100% | 7451.25 | 170 / 170 | 98% | 91.52 | 450 / 459 |
| adipose | 100% | 7597.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 149.67 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 68.98 | 29 / 29 |
| spleen | 100% | 7663.59 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 74.16 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 47.97 | 1 / 1 |
| blood vessel | 100% | 5786.16 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 5741.54 | 799 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 10126.92 | 856 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 61% | 4473.71 | 571 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006487 | Biological process | protein N-linked glycosylation |
| GO_0008250 | Cellular component | oligosaccharyltransferase complex |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0035579 | Cellular component | specific granule membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0019899 | Molecular function | enzyme binding |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MLEC |
| Protein name | Malectin |
| Synonyms | KIAA0152 |
| Description | FUNCTION: Carbohydrate-binding protein with a strong ligand preference for Glc2-N-glycan. May play a role in the early steps of protein N-glycosylation (By similarity). . |
| Accessions | ENST00000228506.8 Q14165 ENST00000412616.2 F5H1S8 ENST00000545525.5 ENST00000535656.1 H0YG07 F5GX14 |